This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2006 Jan;129(1):3-5.

doi: 10.1378/chest.129.1.3.

Beta2 déjà vu

Paul M O'Byrne, Ellinor Adelroth

PMID: 16424402
DOI: 10.1378/chest.129.1.3

Comparative Study

Beta2 déjà vu

Paul M O'Byrne et al. Chest. 2006 Jan.

. 2006 Jan;129(1):3-5.

doi: 10.1378/chest.129.1.3.

Authors

Paul M O'Byrne, Ellinor Adelroth

PMID: 16424402
DOI: 10.1378/chest.129.1.3

No abstract available

PubMed Disclaimer

Comment on

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. Nelson HS, et al. Chest. 2006 Jan;129(1):15-26. doi: 10.1378/chest.129.1.15. Chest. 2006. PMID: 16424409 Clinical Trial.
Formoterol, 24 microg bid, and serious asthma exacerbations: similar rates compared with formoterol, 12 microg bid, with and without extra doses taken on demand, and placebo.
Wolfe J, Laforce C, Friedman B, Sokol W, Till D, Della Cioppa G, van As A. Wolfe J, et al. Chest. 2006 Jan;129(1):27-38. doi: 10.1378/chest.129.1.27. Chest. 2006. PMID: 16424410 Clinical Trial.

Similar articles

Asthma mortality and beta-agonists.
Skorodin MS. Skorodin MS. Chest. 1995 Dec;108(6):1768. doi: 10.1378/chest.108.6.1768. Chest. 1995. PMID: 7497807 No abstract available.
Comments on the Salmeterol Multicenter Asthma Research Trial.
Seymour SM, Sullivan EJ, Chowdhury BA, Meyer RJ, Davi RC. Seymour SM, et al. Chest. 2006 Sep;130(3):930-1; author reply 931. doi: 10.1378/chest.130.3.930. Chest. 2006. PMID: 16963702 No abstract available.
Long acting beta 2 agonists and the risk of life threatening asthma.
Ernst P. Ernst P. Thorax. 1998 Jan;53(1):1-2. doi: 10.1136/thx.53.1.1. Thorax. 1998. PMID: 9577513 Free PMC article. No abstract available.
Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?
Devoy MA, Fuller RW, Palmer JB. Devoy MA, et al. Chest. 1995 Apr;107(4):1116-24. doi: 10.1378/chest.107.4.1116. Chest. 1995. PMID: 7705125 Review. No abstract available.
Salmeterol for the treatment of asthma.
Weinberger M. Weinberger M. Ann Allergy Asthma Immunol. 1995 Sep;75(3):209-11. Ann Allergy Asthma Immunol. 1995. PMID: 7552921 Review. No abstract available.

See all similar articles

Cited by

Long-acting β-agonists in asthma management: what is the current status?
Mysore S, Ruffin RE. Mysore S, et al. Drugs. 2011 Nov 12;71(16):2091-7. doi: 10.2165/11596260-000000000-00000. Drugs. 2011. PMID: 22035511
Management of asthma in adults.
Balter MS, Bell AD, Kaplan AG, Kim H, McIvor RA. Balter MS, et al. CMAJ. 2009 Dec 8;181(12):915-22. doi: 10.1503/cmaj.080007. Epub 2009 Sep 28. CMAJ. 2009. PMID: 19786471 Free PMC article. Review. No abstract available.
Asthma exacerbations . 4: Prevention.
FitzGerald JM, Gibson PG. FitzGerald JM, et al. Thorax. 2006 Nov;61(11):992-9. doi: 10.1136/thx.2005.045195. Thorax. 2006. PMID: 17071835 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information